Pharmaceutical Industry
Exclusive: Pharma industry lobbies Trump for phased tariffs, sources say
Europe's pharma industry braces for tariffs as carve-out hopes fade
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Pharmaceutical Industry Leaders Want to Delay Trump Tariffs
Why Major Pharmaceutical Stocks Tumbled on Tuesday
Pharma industry races to stockpile medicines before potential tariffs
Pharma majors put lobbyists to work to stagger tariff rollout: Reuters
Pharma Industry Braces for Tariffs
Drugs Licensed
Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform (April 1)
Reduce drug spending by drastically simplifying monopolies on drugs
The Woodlands-based company strikes obesity-drug license deal worth up to $1B
Drugs Patents
Reduce drug spending by drastically simplifying monopolies on drugs
8 key drug patents expiring soon — and what it means for the market
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
A closer look at pharma’s top patent losses in 2025
J&J beats Viatris in patent fight over its antipsychotic drug, staving off competition
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
Moore: FDA can save lives by nixing copycat drugs
Generic versus ‘Pioneer’ Drugs: 5 facts you need to know
Drugs Generics
How do drugs get their names - and why are they so hard to pronounce?
Reduce drug spending by drastically simplifying monopolies on drugs
Californians, did you buy any of these prescription drugs? You may get money in a settlement
Generic versus ‘Pioneer’ Drugs: 5 facts you need to know
Federal Circuit Finds Against Generics Where Hatch-Waxman's Full Five-Year Extension Fixes Delay For Pharmaceutical FDA-Review
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
Find out if you're eligible for compensation in $39.1M generic drug price-fixing settlement
Did you overpay for generic drugs? Here’s how NJ residents can check
US tariff threat on Indian generics: What it means for pharma
FDA Food and Drug Administration
Supreme Court throws out ruling against FDA for rejecting fruit- and candy-flavored vaping products
Trump admin live updates: Layoffs begin at HHS, including at the FDA and CDC
Supreme Court backs FDA’s denials of flavored vaping products for now
FDA Removes Top Expert on Vaping and Tobacco
Supreme Court sides with the FDA in its dispute over sweet-flavored vaping products
US Supreme Court tosses ruling faulting FDA for denying flavored vape products
Mass layoffs hit workers at HHS; sweeping cuts extend to CDC, NIH, FDA: Recap
Trump administration cuts FDA staff handling bird flu outbreaks
FDA lays off bird flu leadership, among steep cuts to senior veterinarians
Pharmaceutical Companies
Spanish pharma company Grifols' shares up on Brookfield talk
Pharma Companies Lobby for Delayed, Gradual Drug Tariffs
Exclusive: Pharma industry lobbies Trump for phased tariffs, sources say
Europe's pharma industry braces for tariffs as carve-out hopes fade
US Tariffs on Pharma: THESE companies could be hit the hardest – All you need to know
Pharma industry races to stockpile medicines before potential tariffs
Pharmaceutical Stocks Dive as Top FDA Vaccine Regulator Departs
Is BioMarin Pharmaceutical Inc. (BMRN) The Most Profitable Biotech Stock To Buy Right Now?
25,700 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by KLP Kapitalforvaltning AS